|

NVAX Stock Price: Novavax Inc drops as big name biotech companies inch closer to EUA for COVID-19 vaccine

  • NASDAQ:NVAX falls by 4.08% amidst a broader market selloff stimulus talks stumble in America.
  • Novavax teams with UC Davis Health to test its coronavirus vaccine candidate.
  • COVID-19 vaccine makers watch on as Pfizer expects EUA on Thursday from the FDA. 
NVAX Stock Price: Novavax Inc drops as big name biotech companies inch closer to EUA for COVID-19 vaccine

NASDAQ:NVAX has been somewhat forgotten in the race for Emergency Use Authorization (EUA) of its COVID-19 vaccine, taking a backseat to some of the biotech giants who are anticipating approval over the next couple of weeks. Novavax dropped 4.08% on Wednesday alongside a broader market selloff as US stimulus talks hit another wall in Congress. Investors do not have much to complain about considering shares are still up nearly 3000% over the past 52-weeks, with more to come in 2021 once its COVID-19 vaccine is approved for distribution. 

Novavax announced it is teaming with UC Davis Health to begin a Stage 3 clinical trial that will hopefully mean that its COVID-19 vaccine candidate NVX-CoV2373 will be approved and ready to be distributed by early to midway through 2021. For its part, Novavax has already secured some massive deals including 1 billion doses for India, whenever the vaccine can be produced. The Maryland-based biotech firm also has deals in place with Australia and Canada, amongst other countries, so 2021 could be lining up as a big year for Novavax, which still only commands a $7 billion market cap. 

NVAX stock news

NVAX stock price chart

While Novavax is lagging behind leaders like Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA), early results from its clinical trials had some analysts labelling Novavax as the company to beat in Operation Warp Speed. Pfizer and Moderna will have the first-mover advantage and are already the brands synonymous with ridding the world of COVID-19, but by the end of it, Novavax should be there as well and that is already evident in the large orders it has received. 

Author

More from Stocks Reporter
Share:

Editor's Picks

AUD/USD sits at fresh 10-month lows, nears 0.6700

AUD/USD refreshes ten-month lows below 0.6750 and approaches 0.6700 in Wednesday’s Asian session. Fed rate-hike bets, along with fresh exchange of fire between the US and Iran, underpin the safe-haven US Dollar. Furthermore, the RBA’s dovish tilt weighs on the Aussie and the pair.

USD/JPY defends bids near 159.50 on hawkish BoJ Ueda

USD/JPY is defending bids near 159.50 in the Asian session on Wednesday, holding a three-day losing streak after hawkish commentary from BoJ Governor Ueda supports the Japanese Yen amid looming intervention risks. Meanwhile, escalating Middle East tensions revive US Dollar demand amid hawkish Fed bets, which could limit the pair's downside.



Gold keeps falling as $3,800 gives way; FOMC Minutes eyed

Gold keeps falling and gives up the $3,800 level in the Asian session on Wednesday, hitting its lowest level since September 2025. The US Dollar sits near a 19-month high amid a fresh escalation of US-Iran tensions. This, along with firmer Fed rate-hike expectations, underpins the USD and weighs heavily on the non-yielding bullion. Hawkish Fed commentary and strong US Retail Sales data back bets on aggressive Fed hikes.

Nvidia posts record $115.8B Q3 revenue, but crypto stays muted
The crypto market remained subdued on Tuesday despite Nvidia's (NVDA) Q3 earnings release beating analysts' expectations as demand for artificial intelligence infrastructure continued to drive growth across its business. The AI chipmaker reported record third-quarter revenue of $115.8 billion, up 103% YoY and 20% from the previous quarter.
Nvidia results boost confidence in the post-Huang era

Nvidia’s results have landed without a hitch. The stock price is  rising by more than 4% in post-market trading, and investors are giving a warm welcome to the first set of Nvidia earnings without Jensen Huang at the helm. These earnings were similar, yet different, from what we have come to expect from Nvidia. The numbers were definitely familiar.

Gold isn't being sold for thew reason most people think
Gold (XAU/USD) remains under heavy selling pressure on Monday, hitting its lowest level in 13 months. The precious metal is struggling to recover despite escalating geopolitical tensions in the Middle East, a backdrop that would normally encourage investors to seek protection in safe-haven assets. However, the main driver behind Gold's decline is not the geopolitical uncertainty itself.